| # | Drug | Count |
|---|---|---|
| 0 | DENOSUMAB | 34208 |
| 1 | PREDNISONE | 25263 |
| 2 | METHOTREXATE SODIUM | 19213 |
| 3 | INFLIXIMAB | 18013 |
| 4 | METHOTREXATE | 17408 |
| 5 | ETANERCEPT | 15727 |
| 6 | RITUXIMAB | 14989 |
| 7 | ACETAMINOPHEN | 14562 |
| 8 | ERGOCALCIFEROL | 11478 |
| 9 | GABAPENTIN | 10804 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 5874 | 0.5053 |
| 1 | OMADACYCLINE | 154 | 0.5033 |
| 2 | IVOSIDENIB | 556 | 0.4982 |
| 3 | RITUXIMAB-ABBS | 985 | 0.4855 |
| 4 | RITUXIMAB-PVVR | 243 | 0.4286 |
| 5 | ISAVUCONAZONIUM SULFATE | 653 | 0.3406 |
| 6 | DEFIBROTIDE SODIUM | 672 | 0.3221 |
| 7 | BECAPLERMIN | 672 | 0.3191 |
| 8 | PURIXAN | 183 | 0.3183 |
| 9 | ANAKINRA | 3014 | 0.2816 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 54693 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 39948 |
| 2 | RANK Ligand Inhibitor [EPC] | 34208 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 30227 |
| 4 | Kinase Inhibitor [EPC] | 20171 |
| 5 | Atypical Antipsychotic [EPC] | 19160 |
| 6 | Benzodiazepine [EPC] | 18351 |
| 7 | Platelet Aggregation Inhibitor [EPC] | 18316 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 17369 |
| 9 | CD20-directed Cytolytic Antibody [EPC] | 17319 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Recombinant Antithrombin [EPC] | 7 | 0.4375 |
| 1 | Melanocortin 4 Receptor Agonist [EPC] | 9 | 0.3913 |
| 2 | Antileishmanial [EPC] | 73 | 0.3288 |
| 3 | Human Platelet-derived Growth Factor [EPC] | 672 | 0.3191 |
| 4 | Carbamoyl Phosphate Synthetase 1 Activator [EPC] | 124 | 0.2974 |
| 5 | Lead Chelator [EPC] | 16 | 0.2963 |
| 6 | Interleukin-1 Receptor Antagonist [EPC] | 3014 | 0.2816 |
| 7 | RANK Ligand Inhibitor [EPC] | 34208 | 0.2135 |
| 8 | Lipoglycopeptide Antibacterial [EPC] | 153 | 0.2099 |
| 9 | Growth Hormone Secretagogue Receptor Agonist [EPC] | 1 | 0.2000 |